Several melanomas, carcinomas, glioblastomas and leukemias showed coordinated expression of HOXB7 and bFGF with exception of the SkBr3 mammary carcinoma that was negative for both. Transduction of HOXB7 gene into SkBr3 cells, induced bFGF expression, increased growth rate, independence from serum withdrawal and ability to form colonies in semisolid medium. ELISA assay showed that most of bFGF was associated to cell lysate when cells were cultured at 1% serum whereas in cells kept to 10% serum bFGF was detected both within cell lysate or secreted into cell supernatants. Antisense oligos to bFGF inhibited the growth of cells cultured in 1%, indicating that beside the possible activation of additional genes other than bFGF by HOXB7 transduction, only bFGF induction accounts for the observed results. Moreover, since inhibition of cell proliferation occurred in cells kept in 1% but not 10% serum, a bFGF intracrine loop appears operative in serum starved SkBr3/HOXB7 cells. Also, these results further indicate bFGF as target of HOXB7.
Introduction
Products of homeobox (HOX) genes are transcription factors that control cellular proliferation/dierentiation during development (Krumlauf, 1994; Mavilio, 1993) and are necessary for proliferation of normal adult hematopoietic precursors (Giampaolo et al., 1994; Sauvageau et al., 1994) , NK cells (Quaranta et al., 1996) and T lymphocytes (CareÁ et al., 1994) . The coordinate expression of HOX genes as described in teratocarcinoma (Mavilio 1993) , activated T lymphocytes (CareÁ et al., 1994) and progenitor hematopoietic cells (Giampaolo et al., 1994; Sauvageau et al., 1994) appears to be lost in neoplasias of dierent origin (CareÁ et al., 1996; Cillo et al., 1992) . The oncogenic potential of several murine Hox genes has been demonstrated by in vitro and in vivo transformation assays (Maulbecker and Gruss, 1993) , while divergent human and murine homeobox containing genes such as Pbx1, tcl-3, HB24 and meisl are involved in speci®c chromosomal translocations (Dedera et al., 1993; Hatano et al., 1991) or are associated with dierent leukemias (Deguchi et al., 1993; Moskow et al., 1995) .
Comprehension of HOX genes functions, particularly in neoplasias, is hampered by the limited knowledge of target genes for homeoproteins. In addition to genes coding for adhesion molecules, such as cytotactin (Jones et al. 1992a) , N-CAM (Jones et al., 1992b) and L-CAM (Goomer et al., 1994) , bFGF, one of the major angiogenetic factors in both cancer (Schweigerer et al., 1987) and embryogenesis (Flamme and Risau, 1992) , has been recently described to be directly transactivated by the HOXB7 gene product in melanomas (CareÁ et al., 1996) , where bFGF has been indicated to be responsible of an autocrine loop (Kerbel, 1992) .
To further demonstrate the link between HOXB7 and bFGF, we looked for a cell line negative for expression of both genes and tested whether transduction of HOXB7 was sucient to induce bFGF expression.
Results
A coordinated expression of HOXB7 and bFGF was found in 25 melanoma cell lines, as well as in vivo primary and metastatic melanomas (CareÁ et al., 1996) . Additional tumor cell lines, including four glioblastomas, six carcinomas and ®ve leukemias were screened here by RT ± PCR for HOXB7 and bFGF expression. Among them only the SkBr3, a cell line derived from a breast adenocarcinoma (Trempe and Fogh 1973) , was negative for the expression of both HOXB7 and bFGF ( Figure 1 and data not shown). The retroviral vector LHOXB7SN, carrying the full length cDNAs of HOXB7 and neoR genes, was utilized to transduce the SkBr3 cells. Both LHOXB7SN and empty vector (LXSN) transduced cells were selected with 1.6 mg/ml of G418 and tested for expression of both HOXB7 and bFGF mRNAs by RNase protection. Figure 1a shows that the transduction of HOXB7 results in bFGF expression. Further analyses by Northern blot revealed the normal major transcripts of 7.0, 3.6, 2.2 and 1.2 Kb (Figure 1b) and Western blot showed the expected immunoreactive pattern (18, 22/22.5 and 24 kDa) ( Figure 1c ). These data directly con®rm that HOXB7 induces bFGF expression, but do not indicate whether HOXB7 has any role in tumorigenesis since the SkBr3 cell line is already tumor derived (Trempe and Fogh 1973) . Although it is known that bFGF stimulates growth of both mouse mammary epithelial cells in vitro (Fernig et al., 1993) and human breast cancer cell lines (Fernig and Gallagher, 1994) , we tested whether the expression of bFGF induced by HOXB7 transduction may result in either an increase of cell proliferation or a reduction of growth factor requirement. As a ®rst step we analysed the transduced cells for the expression of bFGF receptors (Fernig and Gallagher, 1994) in SkBr3 cells. Parental as well as HOXB7-transduced SkBr3 cells constitutively express bFGF receptors -2, -3 and -4 (Figure 2 ), indicating that these cells are potentially responsive to bFGF. SkBr3 and SkBr3/ HOXB7 cells were than plated in medium supplemented with 10% or 1% fetal calf serum (FCS) and cell proliferation was measured at dierent times as densitometric increases of methylene blue-treated plates. SkBr3 cells expressing bFGF, because of HOXB7 transduction, increased the proliferation rate of about ten times over non-transduced or empty vector transduced cells (Figure 3a and data not shown) when kept in 10% serum. In addition, the growth rate of cells expressing bFGF was not signi®cantly impaired by dropping the FCS concentration down to 1% (Figure 3a ) or even to 0.1% serum (not shown), whereas parental SkBr3 did not survive in culture when shifted to low serum ( Figure 3a and not shown). We also tested whether the addition of rbFGF may increase proliferation of the SkBr3 parental cell line. A dose/response curve of rbFGF from 10 ± 100 ng/ml was performed, but only a partial increase of proliferative rate was obtained ( Figure 3b ). This result suggests the existence of an intracellular loop of bFGF. To test this possibility, we treated the SkBr3/HOXB7 (7) is the negative control, including all the reaction reagents but RT ± RNA cells, grown in 10% or 1% FCS, with phosphorotioate oligomers complementary to bFGF mRNA sequence and analysed their proliferation. The SkBr3/HOXB7 cell line treated with 30 mM bFGF antisense oligomers showed 80 ± 90% growth inhibition when cultured in 1% serum, but no growth inhibition was detected in cells kept in 10% serum ( Figure 4 ). As expected no inhibition was obtained in the parental SkBr3 cells not expressing bFGF. Thus, bFGF became necessary for proliferation of SkBr3/HOXB7 in condition of serum withdrawal.
Since antisense experiments suggested the existence of an intracrine bFGF pathway, we tested whether bFGF in SkBr3/HOXB7 cells was secreted or retained intracellularly. Cell lysates and supernatants of cultured cells were assayed by ELISA. Most of the detectable bFGF was intracellular (95% of the total bFGF production, corresponding to 10 ng/10 6 cells/ 24 h) in SkBr3/HOXB7 cells grown in 1% FCS, whereas in cells cultured at 10% FCS more bFGF was secreted and the amounts measured in supernatants and cell lysates were roughly the same (3 ± 5 ng/10 6 cells/24 h). No bFGF was detectable in parental SkBr3 cells.
Finally we investigated the eect of HOXB7 expression by SkBr3 cells on their capacity of growing in semisolid medium. Transduced cells showed a cloning eciency of 7+1.6 for 10 3 and 36+8.5 for 10 4 cells plated in 60 mm dishes, while the parental cells were not able to grow.
Discussion
Genes regulating cell proliferation and dierentiation participate to tumorigenesis and/or tumor progression because of their deregulated function or because of their interaction with deregulated target genes. Some murine HOX genes have been described to be able of transforming murine cells both in vivo and in vitro (Maulbecker and Gruss 1993). In humans, some divergent homeobox containing genes are involved in chromosomal translocations or their expression associated with dierent leukemias (Dedera et al., 1993; Deguchi and Kehre 1993; Hatano et al., 1991; Moskow et al., 1995) .
Solid tumors are often characterized by growth factor autocrine loops and growth factor promotion of neo vascularization (Flamme and Risau 1992; Kerbel, 1992; Schweigerer et al., 1987) . In melanomas we have shown that the constitutive expression of HOXB7 was directly responsible of bFGF production, since its downregulation due to antisense oligos treatment abrogated bFGF expression and impaired cell proliferation. A direct interaction between HOXB7 and bFGF promoter was demonstrated by gel shift analysis and cotransfection experiments (CareÁ et al., 1996) .
Here we show that a breast carcinoma cell line, SkBr3 (Trempe and Fogh 1973) , characterized by lack of both HOXB7 and bFGF gene expression, became able of expressing them upon transduction of the sole HOXB7. This result adds important evidence on the direct relationship between a homeogene and bFGF, which is instrumental in driving embryogenesis (Flamme and Risau, 1992) , but also tumor progression if deregulated (Schweigerer et al., 1987) . In fact, SkBr3 trasduced with HOXB7 increased the rate of cell proliferation and partially loose growth factor dependence. Thus, SkBr3/HOXB7, but not the parental cell line, can grow in 1% serum because of HOXB7-induced bFGF production. According to this interpretation, antisense oligos to bFGF abolished such serum independence, clearly indicating a key role for HOXB7-induced bFGF. However, cell-produced bFGF can not be substituted by exogenous recombinant bFGF. This may not be surprising since the mitogenic response to FGFs needs a complex system consisting of both high anity tyrosine kinase and low anity heparan sulphate proteoglycans on the external surface of the cells (Fernig et al., 1993; Fernig and Gallagher, 1994) ; alternatively bFGF can operate through an intracellular loop (Stachowiak et al., 1997) . It is likely that SkBr3 cells may produce low levels of proteoglycans, as reported for some other malignant epithelial cells (Fernig et al., 1993) , but proteoglycans, added together with rbFGF were not sucient to endow serum independence in SkBr3 cells. The most likely explanation of our results relies on an intracrine loop. Thus, beside the above described antisense experiments, SkBr3/HOXB7 producedbFGF was detectable mostly in the cell lysates when cells were cultured in 1% serum, whereas similar amounts of bFGF was measured in lysates and supernatants from cells cultured in 10% FCS. We explained these data by considering that serum starvation could force SkBr3 to utilize bFGF through an intracrine loop, whereas non-limiting serum conditions, by reducing bFGF requirement, allow its secretion. Accordingly stimulation of cell proliferation by intracellular FGFs was observed in several studies and the presence of nuclear FGF receptors postulated (Stachowiak et al., 1997) .
An unsolved question is whether HOXB7, per se, is sucient to induce bFGF expression. Although their coordinate expression has been found in several tumors (CareÁ et al., 1996 and this paper) , it is likely that factors other than HOXB7 may be involved. This can be inferred from our recent observation that cotransfection of HOXB7 and bFGF-CAT reporter plasmid in cells dierent than HeLa were unable to induce CAT activity (unpublished results). COS and NIH3T3 cells were used for such experiments that can be explained by ®guring the need of additional cellular factors cooperating with the HOXB7 product to fully activate the bFGF promoter. These factors could be speciesspeci®c or could be lacking in both COS and NIH3T3 cells. Despite the existence of possible additional mechanisms regulating bFGF expression beside HOXB7 direct interaction with one of the ®ve homeodomain binding sites within its promoter, the data presented in this paper strongly con®rm the role of HOXB7 in bFGF activation and support its possible involvement in the progression of tumors other than melanomas, particularly in breast carcinomas where bFGF has been already shown to be involved in cell proliferation (Peyrat et al., 1992) .
Materials and methods
Cell line culture and transduction LHOXB7SN was constructed by cloning the full length coding sequence of the human HOXB7 gene (Simeone et al., 1987) in the HpaI/BamHI sites of the LXSN retroviral vector (Miller and Rosman, 1989) . Plasmid vector was transfected into the gp+E86 packaging cell line (Markowitz et al., 1988) by standard calcium phosphate coprecipitation, and the supernatant of 48 h cultures was used to infect the amphotropic gp+AM12 packaging line. Infected gp+AM12 cells were selected with 0.8 mg/ml of G418 and used to generate helper-free virus-containing supernatant. The viral titer of the selected packaging cell clone was 1.3610 6 p.f.u. ml. For target infection, 3610 5 cells were treated for 4 h with undiluted packaging cell supernatants in the presence of 8 mg/ml of Polybrene. After a medium change, cells were grown for 48 h and then selected with G418 (1.6 mg/ml).
Synthetic oligomers
PCR ampli®cation Unmodi®ed 18-mer deoxynucleotides were synthesized and puri®ed by ethanol precipitation according to standard procedures.
Antisense oligomers Phosphorothioate oligomers (NBI, Plymouth, MA), which are characterized by increased cell uptake and stability, were used for antisense inhibition experiments.
RNA analysis
Reverse transcription-polymerase chain reaction (RT ± PCR) RT ± PCR was performed according to standard procedures, as reported in ref The sequences of the other primers and probes, as well as PCR conditions, are reported elsewhere (CareÁ et al., 1996) .
RNase protection
RNase protection analysis was performed according to standard procedures (Sambrook et al., 1989) . Hybridization was carried out overnight at 558C, RNase digestion for 1 h at 378C, and urea-acrylamide electrophoresis was run at 558C. DNA fragments to be transcribed consisted of a speci®c sequence 3' to the box for HOXB7, 139 bp Smal ± TaqI. bFGF was a 280 bp HincII fragment. The bactin insert was a 93-bp RsaI fragment, always labeled in the presence of cold GTP to obtain a low speci®c activity.
Northern blot
Northern blot analysis was performed according to standard procedures (Sambrook et al., 1989 ) on 2 ± 3 mg of selected poly (A) + RNA.
Growth assay
The proliferative rate of parental and transduced-SkBr3 cells was evaluated by a spectrophotometric assay. Brie¯y, 2610 5 cells were cultured for dierent times; wells were thus ®xed with 5% formalin in water and stained with 1% methylene blue in 0.01 M borate buer, pH 8.0. After several washes, the dye was eluted from the cells with 0.1 M HCl and absorbance read at 620 nm.
ELISA
Intracellular and secreted bFGF were quanti®ed by a human bFGF ELISA from R&D systems (Minneapolis, MN). Dierent concentrations of cells ranging from 10 5 /ml to 10 6 /ml were cultured for 24 and 48 h and their cell lysates and culture media were collected and stored at 7808C until use. To prepare cell lysates, cells were washed in PBS and resuspended in 10 mM Tris-HCI pH 7.4, containing 1 M NaCl, 1 mM PMSF and 10 mg/ml aprotinin. The cells were disrupted by three cycles of freeze-thawing and the homogenate centrifuged at 30 000 g for 30 min.
Western blot analysis
A rabbit polyclonal anti-serum to human bFGF was used (Oncogene Res. Prod., Cambridge, MA). Equal amounts of total protein were separated by SDS-12.5% PAGE and transferred to a nitrocellulose ®lter by electroblotting. Filters were incubated 1 h, at room temperature, with 1 mg/ ml anti-serum and the primary antibody was detected with peroxidase -conjugated sheep anti-rabbit IgG.
Antisense experiments

Cells (2610
3 ) of each sample were incubated in triplicate in 96-well plates in 0.2 ml of culture medium supplemented with 10% fetal bovine serum, heat-inactivated for 30 min at 658C to destroy nucleases. Cells were cultured in the presence or absence of antisense and sense phosphorothioate oligomers. To demonstrate the absence of toxicity and the speci®city of inhibition and to minimize the possibility of crossreaction with unrelated genes both sense and antisense sequences were ®rst tested against the EMBL data bank. The antisense oligomers were complementary to the translation start site. Oligomers at concentrations of 30 mM were added 24 h after cell plating and proliferation was tested on day 7. bFGF antisense sequence was 5'-TAGCTTGATGTGAGG-3'. Antisense inhibition was calculated relative to that of sense-treated cells whose inhibition never exceeded 25% of the proliferation rate shown by their untreated counterparts. For RT ± PCR analysis, on the last day of culture, cells from the third well of each sample were lysed for total RNA extraction by a modi®cation of the guanidine-thiocyanate CsCl gradient made in a microultracentrifuge (TL-100, Beckman Inst., Palo Alto, CA) in the presence of ribosomal RNA as carrier.
Growth in semisolid medium
Base layers of complete DME medium containing 0.5% agar were set in 60 mm plastic dishes. The bottom agar was overlaid with 1.5 ml of 0.33% agar containing suspensions of 10 3 or 10 4 cells. Cultures were incubated for 2 ± 3 weeks at 378C and the colonies counted using an inverted microscope. Two experiments were performed and results are calculated as the average of three dishes for each condition.
Abbreviations bFGF, basic Fibroblast Growth Factor; HOX, Homeobox; FCS, fetal calf serum
